'; var fr = document.getElementById(adID); setHash(fr, hash); fr.body = body; var doc = getFrameDocument(fr); doc.open(); doc.write(body); setTimeout(function() {closeDoc(getFrameDocument(document.getElementById(adID)))}, 2000); } function renderJAd(holderID, adID, srcUrl, hash) { document.dcdAdsAA.push(holderID); setHash(document.getElementById(holderID), hash); document.dcdAdsH.push(holderID); document.dcdAdsI.push(adID); document.dcdAdsU.push(srcUrl); } function er_showAd() { var regex = new RegExp("externalReferrer=(.*?)(; |&|$)", "gi"); var value = regex.exec(document.cookie); if (value && value.length == 3) { var externalReferrer = value[1]; return (!FD.isInternalReferrer() || ((externalReferrer) && (externalReferrer > 0))); } return false; } function isHome() { var loc = "" + window.location; loc = loc.replace("//", ""); var tokens = loc.split("/"); if (tokens.length == 1) { return true; } else if (tokens.length == 2) { if (tokens[1].trim().length == 0) { return true; } } return false; } function checkAds(checkStrings) { var cs = checkStrings.split(","); for (var i=0;i 0 && cAd.innerHTML.indexOf(c)>0) { document.dcdAdsAI.push(cAd.hash); cAd.style.display ='none'; } } } //Check iframes if (!ie) { for (var i=0;i 0 && doc.body.innerHTML.indexOf(c)>0) { document.dcdAdsAI.push(fr.hash); fr.style.display ='none'; } } } } } if (document.dcdAdsAI.length > 0 || document.dcdAdsAG.length > 0) { var pingServerParams = "i=" var sep = ""; for (var i=0;i 0) { var pingServerUrl = "/action/pingServerAction?" + document.pingServerAdParams; var xmlHttp = null; try { xmlHttp = new XMLHttpRequest(); } catch(e) { try { xmlHttp = new ActiveXObject("Microsoft.XMLHttp"); } catch(e) { xmlHttp = null; } } if (xmlHttp != null) { xmlHttp.open( "GET", pingServerUrl, true); xmlHttp.send( null ); } } } function initAds(log) { for (var i=0;i 0) { doc.removeChild(doc.childNodes[0]); } doc.open(); doc.write(fr.body); document.dcdsAdsToClose.push(fr.id); } } else { fr.src = fr.src; } } } if (document.dcdsAdsToClose.length > 0) { setTimeout(function() {closeOpenDocuments(document.dcdsAdsToClose)}, 500); } } } var ie = isIE(); if(ie && typeof String.prototype.trim !== 'function') { String.prototype.trim = function() { return this.replace(/^\s+|\s+$/g, ''); } } document.dcdAdsH = new Array(); document.dcdAdsI = new Array(); document.dcdAdsU = new Array(); document.dcdAdsR = new Array(); document.dcdAdsEH = new Array(); document.dcdAdsE = new Array(); document.dcdAdsEC = new Array(); document.dcdAdsAA = new Array(); document.dcdAdsAI = new Array(); document.dcdAdsAG = new Array(); document.dcdAdsToClose = new Array(); document.igCount = 0; document.tCount = 0; var dcOrd = Math.floor(100000000*Math.random()); document.dcAdsCParams = ""; var savValue = getAdCookie("sav"); if (savValue != null && savValue.length > 2) { document.dcAdsCParams = savValue + ";"; }

The Sydney Morning Herald

Breaking News Technology

• NSW
• National
• World
• Business
• Sport
• Environment
• National Times
• Tech
• Digital Life
• Entertainment
• Life & Style
• Travel
• Cars
• Exec Style

You are here: Home Breaking News Technology Article

Kidney dialysis services provider DaVita Inc. said Monday that it has agreed to buy the doctor network operator HealthCare Partners in a cash-stock deal worth about $4.42 billion.

Denver-based DaVita said it will pay about $3.66 billion in cash and contributed common stock valued at $758 million as of last Friday to the deal. It also could pay an additional $275 million in cash if HealthCare Partners achieves performance targets this year and next.

HealthCare Partners manages and runs medical groups and doctor networks, with operations in California, Nevada and Florida. It coordinates care for more than 667,000 patients and provides primary and specialty doctor care. HealthCare Partners had $2.4 billion in revenue last year.

DaVita operates or provides administrative services at 1,841 dialysis facilities in the United States and also runs 15 outpatient dialysis centers in three other countries. It will use available cash, its senior secured credit facilities and more debt financing for the deal's cash portion.

The deal is still subject to approval by HealthCare Partners owners and other closing conditions. The companies expect to close the deal in the fourth quarter.

After the closing, the combined company will be named DaVita HealthCare Partners Inc., DaVita said in a statement.

© 2012 AP DIGITAL
This story is sourced direct from an overseas news agency as an additional service to readers. Spelling follows North American usage, along with foreign currency and measurement units.

• Latest videos

...